PP  Vol.5 No.2 , February 2014
Safe Use and Disposal of Injections: Saudi Health Providers’ Perception
Abstract: Injection is said to be safe when causing no harm to the recipient, and it does not expose provider to avoidable risk and does not result in any waste that is dangerous for other people. Purpose: The study was carried out to determine the perspectives of the Saudi health care providers on the safe use and disposal of injection. Methods: Prospective cross sectional survey was used, structured interviews were carried out by the use of pretested questionnaire to elicit general opinions on injection practices skills, and disposal processes in different health settings in Taif Area. Results: Females were dominant injection providers 82.3%. About 80% of providers tend to discard single use injection at once after administration and 84% tend to safely dispose them. Hygienic measures were well maintained. Increased used pattern of injection was observed 46%. Providers were well satisfied by the measures adopted to curb after using hazards. High rate of injection sticks 74.3% was observed. Conclusion: Although some measures of safe disposal were maintained by Saudi injections’ providers, still some regulation efforts should be done to curb spreading out of infection due to mal use and disposal of injection.
Cite this paper: A. Albarraq, "Safe Use and Disposal of Injections: Saudi Health Providers’ Perception," Pharmacology & Pharmacy, Vol. 5 No. 2, 2014, pp. 153-159. doi: 10.4236/pp.2014.52021.

[1]   S. Gyawali, D. S. Rathore, P. R. Shankar and K. C. Vikash Kumar, “Strategies and Challenges for Safe Injection Practice in Developing Countries,” Journal of Pharmacology and Pharmacotherapeutics, Vol. 4, No. 1, 2013, pp. 8-12.

[2]   Y. J. Hutin, A. M. Hauri and G. L. Armstrong, “Use of Injections in Health Care Settings Worldwide, 2000: Literature Review and Regional Estimates,” BMJ, Vol. 327, No. 7423, 2003, pp. 1075-1078.

[3]   E. Drucker, P. G. Alcabes and P. A. Marx, “The Injection Century: Massive Unsterile Injections and the Emergence of Human Pathogens,” Lancet, Vol. 358, No. 9297, 2001, pp. 1989-1992.

[4]   M. Kermode, W. Holmes, B. Langkham, M. S. Thomas and S. Gifford, “Safer Injections, Fewer Infections: Injection Safety in Rural North India,” Tropical Medicine & International Health, Vol. 10, No. 5, 2005, pp. 423-432.

[5]   Geneva: World Health Organization (WHO), “Safety of Injections Question and Answers,” Publication No. WHO/EHT/04.06, Secretariat of the Safe Injection Global Network, Department of Essential Health Technologies, 2011.

[6]   H. Riaz, S. W. Kamal, T. Riaz, S. Aziz, J. Rajper and W. Noorulain, “Methods of Disposal of Used Syringes by Hepatitis B and C Patients at an Urban and Rural Setting,” Journal of Pakistan Medical Association, Vol. 62, No. 1, 2012, pp. 81-84.

[7]   A. Kane, J. Lloyd, M. Zaffran, L. Simonsen, M. Kans, et al., “Transmission of Hepatitis B, Hep C and HIV through Unsafe Injections in the Developing World; Model Based Regional Estimates,” Bull World Health Organ, Vol. 77, No. 10, 1999, pp. 801-807.

[8]   WHO, The World Health Report 2002. Reducing Risks, Promoting Healthy Life 2002.

[9]   B. S. Hersh, R. M. Carr, J. Fitzner, et al., “Ensuring Injection Safety during Measles Immunization Campaigns: More than Auto-Disable Syringes and Safety Boxes,” The Journal of Infectious Diseases, Vol. 187, No. Suppl 1, 2003, pp. S299-S306.

[10]   L. Simonsen, A. Kane, J. Lloyd, M. Zaffran and M. Kane, “Unsafe Injections in the Developing World and Transmission of Bloodborne Pathogens: A Review,” Bull World Health Organ, Vol. 77, No. 10, 1999, pp. 789-800.

[11]   A. Battersby, R. Feilden, P. Stoeckel, A. Da Silva, C. Nelson and A. Bass, “Strategies for Safe Injections,” Bull World Health Organ, Vol. 7, No. 12, 1999, pp. 996-1000.

[12]   S. Kalra, Y. P. S. Balhara, M. P Baruah, M. Chadha, H. B. Chandalia, S. Chowdhury, K. M. P. Kumar, S. Modi, S. Pitale, R. Shukla, R. Sahay, A. Sundaram, A. G. Unnikrishnan and S. K. Wangnoo, “Forum for Injection Techniques, India: The First Indian Recommendations for Best Practices in Insulin Injection Technique,” Indian Journal of Endocrinology and Metabolism, Vol. 16, No. 6, 2012, pp. 876-885.

[13]   M. A. Makary, A. Al-Attar, C. G. Holzmueller, J. B. Sexton, D. Syin, M. M. Gilson, M. S. Sulkowski and P. J. Pronovost, “Needlestick Injuries among Surgeons in Training,” The New England Journal of Medicine, Vol. 356, No. 26, 2007, pp. 2693-2699.

[14]   S. Wicker, F. Nürnberger, J. B. Schulze and H. F. Rabenau, “Needlestick Injuries among German Medical Students: Time to Take a Different Approach?” Medical Education, Vol. 42, No. 7, 2008, pp. 742-745.

[15]   K. P. Prakash, “Epidemiology of Needle-Stick Injuries in Mangalore,” Journal of Evolution of Medical and Dental Sciences, Vol. 1, No. 3, 2012, p. 128.

[16]   F. Shiva, A. Sanaei, A. R. Shamshiri and F. Ghotbi, “Survey of Needle-Stick Injuries in Paediatric Health,” Journal Pakistan Medical Association, Vol. 61, No. 2, 2011, pp. 127-131.

[17]   E. Drucker, P. Lurie, A. Wodak and P. Alcabes, “Measuring Harm Reduction: The Effects of Needle and Syringe Exchange Programs and Methadone Maintenance on the Ecology of HIV,” AIDS, Vol. 12, No. Suppl A, 1998, pp. S217-S230.

[18]   A. Khushdil, H. Farrukh, M. D. Sabir, T. Awan and T. Qureshi, “Needle Stick Injuries in Nursesat A Tertiary Health Care Facility,” Journal of Postgraduate Medical Institute, Vol. 27, No. 4, 2013, pp. 381-386.

[19]   A. Onyemocho1, J. I. Anekoson and E. O. Pius, “Knowledge and Practice of Injection Safety among Workers of Nigerian Prison Service Health Facilities in Kaduna State,” American Journal of Public Health Research, Vol. 1, No. 7, 2013, pp. 171-176.

[20]   A. A.-R. Mahfouz, I. Abdelmoneim, M. Y. Khan, A. A. Daffalla, M. M. Diab. H. Shaban and H. S. Al Amri, “Injection Safety at Primary Health Care Level in South-Western Saudi Arabia,” Eastern Mediterranean Health, Vol. 15, No. 2, 2009, pp. 443-450.

[21]   Y. Hutin, A. Hauri, L. Chiarello, M. Catlin, B. Stilwell, T. Ghebrehiwet and J. Garner, “Best Infection Control Practices for Intradermal, Subcutaneous, and Intramuscular Needle Injections,” Bull World Health Organ, Vol. 81, No. 7, 2003, pp. 491-500.

[22]   D. E. Koziol and D. K. Henderson, “Risk Analysis and Occupational Exposure to HIV and HBV,” Current Opinion in Infectious Diseases, Vol. 6, No. 4, 1993, pp. 506-510.

[23]   S. B. Omer, D. A. Salmon, W. A. Orenstein, M. P. de Hart and N. Halsey, “Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases,” The New England Journal of Medicine, Vol. 360, No. 19, 2009, pp. 1981-1988.

[24]   H. V. Wyatt, “The Popularity of Injections in the Third World: Origins and Consequences for Poliomyelitis,” Social Science & Medicine, Vol. 19, No. 9, 1984, pp. 911-915.

[25]   F. P. Mitrano, R. J. Baptista, D. W. Newton and S. C. Augustine, “Microbial Contamination Potential of Solutions in Prefilled Disposable Syringes Used with a Syringe Pump,” American Journal of Hospital Pharmacy, Vol. 43, No. 1, 1986, pp. 78-80.